A gloved hand holding a blood glucose meter showing a reading

Type 2 diabetes

Also called diabetes, T2D, prediabetes, high blood sugar, insulin resistance, adult-onset diabetes

The body stops using insulin well and blood sugar runs high. It can often be prevented, and sometimes put into remission, with weight loss, and newer drugs also protect the heart and kidneys.

Updated 5 sources

Photo: Alabama Extension (CC0)

This entry is a draft and is still being reviewed.

Types

  • Prediabetes — blood sugar above normal but below the diabetes range1.
  • Type 2 diabetes — insulin resistance combined with gradually failing insulin production; 90–95% of all diabetes1.
  • Related forms that can be mistaken for it: type 1 (autoimmune) diabetes, gestational diabetes, and monogenic diabetes (MODY)1.

Prevention

In the Diabetes Prevention Program, a lifestyle program aiming for 7% weight loss and 150 minutes of activity a week cut the risk of developing diabetes by 58%; metformin cut it by 31%2.

Risk factors

  • Overweight or obesity, especially around the waist1
  • Physical inactivity2
  • A parent or sibling with diabetes1
  • Age 35 and older1
  • Prediabetes, or diabetes during a past pregnancy1
  • Higher risk among Black, Hispanic/Latino, American Indian, Asian American, and Pacific Islander people1
  • High blood pressure, low HDL or high triglycerides, and polycystic ovary syndrome1

Diagnostics

Diabetes is diagnosed by any one of these, usually confirmed with a second test1:

  • HbA1c of 6.5% or higher (prediabetes: 5.7–6.4%)
  • Fasting plasma glucose of 126 mg/dL or higher (prediabetes: 100–125)
  • Two-hour glucose of 200 mg/dL or higher on an oral glucose tolerance test (prediabetes: 140–199)
  • Random glucose of 200 mg/dL or higher with classic symptoms such as thirst and frequent urination

The ADA recommends screening every adult from age 35, and younger adults with overweight or obesity plus another risk factor1.

Treatments

  • Lifestyle and weight loss are the foundation of treatment2,4.
  • Remission is possible. In the DiRECT trial, a structured weight-management program put 46% of participants into remission at one year, including 86% of those who lost 15 kg (33 lb) or more4.
  • Medication is chosen around your goals: lowering blood sugar, losing weight, and protecting the heart and kidneys5.
  • Monitoring: HbA1c every 3 to 6 months; many people also use continuous glucose monitors.
  • Complication screening: yearly eye, kidney, and foot checks, plus blood pressure and cholesterol control.

Molecular Biomarkers

  • HbA1c — average blood sugar over roughly three months1.
  • Fasting and after-meal glucose1.
  • C-peptide and islet autoantibodies (such as GAD65) — help tell type 2 from type 1 when the picture is unclear1.
  • Urine albumin-to-creatinine ratio and eGFR — catch early kidney damage.

Genes

  • TCF7L2 carries the strongest common genetic risk variant for type 2 diabetes3.
  • Hundreds of other variants each add a small amount of risk; family history captures much of it.
  • Monogenic diabetes (MODY), caused by single genes such as HNF1A, HNF4A, and GCK, should be considered in young people with diabetes and a strong family history, because the treatment is different1.

Lifestyle

  • Aim for at least 150 minutes a week of moderate activity, plus strength training, and break up long periods of sitting2.
  • Losing 5–7% of body weight improves blood sugar and can stop prediabetes from progressing2.
  • Don't smoke, and protect your sleep.

Nutrition

  • No single diet is best. Mediterranean, lower-carbohydrate, DASH, and plant-based patterns all help when they fit your life.
  • Cut sugary drinks and refined starches; build meals around vegetables, legumes, whole grains, and fiber.
  • In DiRECT, remission came from total diet replacement — low-calorie formula shakes for 12 to 20 weeks, then a gradual return to food4.

Medical Interventions

  • Metabolic (bariatric) surgery for people with obesity, which often leads to remission
  • Continuous glucose monitors, and insulin pumps for people who use insulin

Pharmaceutical Drugs

  • GLP-1 receptor agonists: semaglutide, dulaglutide, liraglutide5
  • Dual GIP/GLP-1 receptor agonist: tirzepatide5
  • SGLT2 inhibitors: empagliflozin, dapagliflozin, canagliflozin5
  • Metformin5
  • DPP-4 inhibitors, sulfonylureas, and pioglitazone5
  • Insulin when other treatments aren't enough5
  • For people with heart disease, heart failure, or kidney disease, the ADA recommends a GLP-1 receptor agonist or SGLT2 inhibitor with proven benefit regardless of blood sugar level5.

Sources

  1. American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S27-S49. doi:10.2337/dc26-S002
  2. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. doi:10.1056/NEJMoa012512
  3. Grant SFA, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38(3):320-323. doi:10.1038/ng1732
  4. Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541-551. doi:10.1016/S0140-6736(17)33102-1
  5. American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S183-S215. doi:10.2337/dc26-S009

This page summarizes published research for education. It isn't medical advice and doesn't replace care from a clinician who knows your history. Never start, stop, or change a medication without talking to your prescriber.